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Abstract
Introduction: The epidemic of HIV in sub-Saharan Africa varies significantly across countries in the region with high
prevalence in Southern Africa and Nigeria. Cancer is increasingly identified as a complication of HIV infection with
higher incidence and mortality in this group than in the general population. Without cancer prevention strategies,
improved cancer treatment alone would be an insufficient response to this increasing burden among people living
with HIV (PLHIV). Although previous studies have noted low levels of awareness of cancers in sub-Saharan Africa
none has examined the knowledge and perceptions of cancer among people living with HIV/AIDS.
Methods: Focus group discussions (FGD) and Key Informant Interviews (KII) were carried out in 4 high volume
tertiary care institutions that offer HIV care and treatment in Nigeria. FGD and KII assessed participants’ knowledge
of cancer, attitudes towards cancer risk and cancer screening practices.
Results: The mean age (SD) of the FGD participants was 38 (2.8) years. Most participants had heard about cancer
and considered it a fatal disease but displayed poor knowledge of the causes of cancer in general and of AIDs
associated cancers in particular. PLHIV in Nigeria expressed fear, denial and disbelief about their perceived cancer
risk. Some of the participants had heard about cancer screening but very few participants had ever been screened.
Conclusion: Our findings of poor knowledge of cancer among PLHIV in Nigeria indicate the need for health care
providers and the government to intervene by developing primary cancer prevention strategies for this population.
Keywords: Knowledge, Attitudes, Practices (KAP), People living with HIV (PLHIV), HIV-associated cancers, Cancer
screening
Introduction
Sub-Saharan Africa accounts for 68% of all HIV infected
persons worldwide (22.9 million out of 34 million) and
75% of AIDS-related deaths (1.2 million out of 1.8 million)
[1]. The epidemic in sub-Saharan Africa varies significantly
across the continent with high prevalence in Southern Af-
rica and Nigeria [2]. In Nigeria, the sero-prevalence of
HIV among adults aged 15–49 years was 4.1% in 2010 [3].
HIV infection is associated with several co-morbidities
including opportunistic infections, (e.g. tuberculosis) and
cancers that are responsible for AIDS associated
mortality [4,5]. In developed countries where the HIV
epidemic has matured and most people living with HIV
(PLHIV) are on anti-retroviral therapy, cancer is now re-
sponsible for at least a third of all mortality [6]. The in-
cidence of cancer among PLHIV in developing countries
too has increased but there is insufficient data on actual
incidence and prevalence [7,8].
Cancer is a major source of morbidity and mortality
worldwide. In 2008, there were 12.7 million new cases
and 7.6 million cancer-related deaths [9]. Projections
show that by 2030, cancer will cause 17 million deaths
with 70% of these expected to occur in developing coun-
tries [10]. Infections including HIV, Hepatitis B and C
virus infections and Human papilloma virus infections
account for about 30% of incident cancers in developing
countries in contrast with developed countries where it
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accounts for about 5%. HIV has emerged as one of the
major infectious risk factors being associated with can-
cers such as – Kaposi Sarcoma, Non-Hodgkin’s Lymph-
oma (NHL) and cervical cancer (CC) collectively
referred to as AIDS Defining Cancers and other cancers
like Lung Cancer, Anal Cancer and Cancer of the Con-
junctiva [11].
In many parts of Africa, HIV treatment and preven-
tion is supported by the President’s Emergency Plan for
AIDS relief (PEPFAR) and this has led to significant im-
provement in the overall morbidity and mortality of
HIV. As a result of this intervention, survival of PLHIV
has increased and the incidence of some AIDS Defining
Cancers like NHL and KS have begun to reduce while
the incidence of Non-AIDS Defining Cancers (NADCs)
are now increasing [12,13]. Given that cancers in re-
source constrained settings tend to present at advanced
stages with limited treatment options [5], preventive
and early detection measures such as health education
and screening are necessary as part of a comprehensive
approach to improved management of people living with
HIV [14].
Previous studies have noted low levels of awareness of
cancers in sub-Saharan Africa [15,16] and high levels of
patronage of alternate medical practitioners [17]. They
also identified the need to provide contextual and cul-
turally sensitive health education [18]. Therefore, cancer
awareness and education efforts directed at PLHIV that
takes advantage of their more frequent contact with the
health care systems are needed to mitigate their higher
cancer risk due to HIV infection [19].
Assessment of the knowledge, attitudes and practices
of malignancies among PLHIV is an essential first step
to determining the most effective approach to cancer
education in this at-risk population. In this study, we
used focus group discussions and key informant inter-
views to elucidate information on the level of awareness,
attitudes and practices of cancer among PLHIV and the
health care professionals who care for them in Nigeria.
The level of awareness of cancer among the general
population in Nigeria is low [18,20] and we hypothesized
that it will be low among PLHIV particularly about those
cancers that are more common in this population and
less so in the general population [21-25].
Materials and methods
We conducted a multi-site study at 4 health institutions
that offer HIV care and treatment services in Nigeria -
the University of Benin Teaching Hospital (UBTH) and
the Nnamdi Azikiwe University Teaching Hospital
(NAUTH) located in southern Nigeria, and the Federal
Medical Centre Keffi (FMC Keffi) and the University of
Abuja Teaching Hospital (UATH) in North-Central
Nigeria. These sites where selected because they are
hospitals where the Institute of Human Virology Nigeria
provides PEPFAR services. They have the highest vol-
ume of clients accessing care and treatment of all the
IHVN supported hospitals and we expected that we
would get a wider variety of participants from these hos-
pitals. In addition, to make this study more nationally
relevant, we selected 2 hospitals from the North of the
country and 2 from the south to ensure an even geo-
graphic spread.
We conducted 8 focus group discussions (FGD) (2 per
institution) to determine the knowledge, attitudes and
practices of PLHIV and non-PLHIV about AIDS asso-
ciated Malignancies. We randomly selected PLHIV parti-
cipants using a computer generated list of random
numbers from the Institute of Human Virology (IHVN)
database of HIV+ clients receiving care and treatment at
the 4 hospitals. The HIV- participants were selected from
patients or relatives of patients who were at the General
Outpatient Department at the selected hospitals on the
date of the focus group discussions. These persons were
approached and invited to participate in a discussion on a
pertinent health problem and were not told before-hand
that this discussion would be about cancer. Recruitment
continued until there was a group of ten people for each
of the two groups at each site. Written informed consent
was obtained from all individuals who were willing to par-
ticipate in the study. FGDs were conducted separately for
HIV+ and HIV- groups of 10 persons. The groups were
heterogeneous and contained both male and female parti-
cipants in each group. Participants had a wide variety of
educational backgrounds from primary to tertiary educa-
tion. The discussions lasted approximately 45–60 minutes,
were managed by a researcher and a note-taker and were
carried out in English language.
We also conducted Key Informant Interviews (KII)
with 8 HIV care providers, 2 persons per institution -
one doctor and one nurse - directly involved in the
management of PLHIV. The participants for the KII
were selected by visiting the Special Care and Treat-
ment Clinic (STC) and interviewing the doctors and
nurses that had run the clinic and seen patients on the
day the FGD were carried out.
Data was audio recorded, and recordings were tran-
scribed by the study staff. The data was transcribed by a
member of the team who did not partake in carrying out
the focus group discussions or key informant interviews.
Handwritten notes taken during the interviews were
used to supplements the audio recordings. Analysis was
done using a thematic analysis. First we identified the
themes and subthemes using both a priori and inductive
approaches. Then we selected the themes most import-
ant to the study. Recurring themes were identified and
grouped according to thematic areas. Comments were
identified as recurring if two or more participants gave
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the same response. We subsequently developed a coding
scheme using the open coding method by extracting
major themes expressed by the participants and then
coding sentences according to the various themes.
Themes were analyzed for each question within individ-
ual focus group session as well as across the eight group
sessions. Themes and conclusions were reviewed to en-
sure that the data was accurately reflected.
The FGD guide was developed by both authors based
on the literature and according to the following
domains: (1) Knowledge of cancer, its causes and know-
ledge of AIDS associated malignancies, (2) Attitude to-
wards cancer risk, cancer screening, cancer diagnosis
and treatment (3) Practices of cancer screening. We
asked the participants open-ended questions about their
knowledge of cancer, how they heard about cancer, what
they think causes cancer, if they think they are at risk of
cancer and if cancer can be treated. We also asked if
they had ever been screened for cancer and their percep-
tions about why patients with cancer present late to hos-
pitals. For the Key Informant Interviews, the guide
contained domains on knowledge of cancer, cancer risk
perception, attitude towards patients with cancer, know-
ledge of cancer screening, perception of PLHIV attitudes
towards cancer screening, cancer diagnosis and treat-
ment. For the purpose of this manuscript, the analysis
and results focus on the following three major themes:
 Knowledge of cancer
 Attitudes towards cancer risk
 Practices of cancer screening
Quotations that best illustrated the themes of interest
were selected and included in the manuscript. Data from
the FGDs were transcribed with no unique identifiers or
names used in the transcripts. The audio recordings
were kept in a password protected laptop. Participants
were assured of confidentiality of their discussions be-
fore they signed the informed consent forms.
The demographic data of the study participants in-
cluding gender, marital status and educational status
were collected and are presented in a tabular format in
our results. When the focus group discussions were over,
participants were given 500 Nigerian Naira ($3.50) to
thank them for their time and contribute to their trans-
portation costs. This study was approved the Institute of
Human Virology Nigeria’s Ethics Committee.
Results
FGD Sample description
There were 80 participants, 20 from each of the 4 partici-
pating hospital sites. The participants’ ages ranged from
18 to 65 years with mean (SD) of 38 (2.8) years. Majority
of FGD participants were women (60%). Most, 64% of
participants had attained at least secondary level educa-
tion, 30% had tertiary education and 6% had only primary
level education. About two-thirds of the participants were
married (66%), 24% were single, 5% were separated and
5% were co-habiting. (Table 1)
Knowledge of cancer
Most, (80%) participants had heard about cancer and
considered it a fatal disease but displayed poor know-
ledge of its causes. (Table 2) Knowledge about AIDS de-
fining cancers such as Cervical Cancer, Kaposi Sarcoma
(KS) and Non-Hodgkin’s Lymphoma (NHL) were par-
ticularly poor although most had heard about breast
cancer. Participants identified electronic media, newspa-
pers, and health talks at hospitals as the medium
through which they had heard about cancer. Most
respondents did not believe that it is possible to have
HIV and cancer though some opined that it may be pos-
sible since both were caused by viruses. A few of them
believed that cancer can be treated if caught early but
most were of the opinion that cancer is a deadly disease
that has no cure.
The knowledge of cancers was similar among PLHIV
and those who were not living with HIV/AIDS. How-
ever, there were differences in the level of knowledge
comparing FGD participants in the institutions in
northern part of the country with those in the southern
part. Participants in the south were more knowledgeable
Table 1 Description of PLHIV and non-PLHIV FGD
participants
No. of
PLHIV
participants
No. of
Non-PLHIV
participants
Total no. in
both PLHIV
and non-PLHIV
(% of total)
Gender
Male 18 14 32 (40)
Female 22 26 48 (60)
Total 40 40 80 (100)
Educational Status
Primary level 431 1 5(6)
Secondary level (high
schoolequivalent
20 51(64)
Tertiary level 5 19 24(30)
Total 40 100 100
Marital Status
Married 30 23 53(66)
Single 8 11 19(24)
Separated/
widowed
4 4 4(5)
Co-habiting 2 2 4(5)
Total 40 40 80(100)
Jedy-Agba and Adebamowo Infectious Agents and Cancer 2012, 7:28 Page 3 of 8
http://www.infectagentscancer.com/content/7/1/28
about cancer and AIDS associated cancers than those in
the north. No participants from the 2 hospitals in the
north had ever heard about cervical cancer, Kaposi sar-
coma or Non- Hodgkin’s lymphoma. However, some
participants from the south who had attained tertiary
education specifically mentioned Kaposi sarcoma as an
AIDS associated cancer while another said, “I heard that
lymphoma at the neck can be seen in people with HIV.”
Women also appeared more knowledgeable about can-
cer than men.
Attitudes towards cancer/cancer risk
FGD participants admitted to being ‘very scared’ when-
ever the word cancer was mentioned (Table 3). Many did
not believe that they could develop cancer. One of the
PLHIV participants voicing her disbelief said ‘it is not
possible for me to get cancer, God will not allow it’. They
were also concerned about the cost of treatment.
(Table 3) Participants considered cancer to be a fatal con-
dition, one which has no treatment except through
“supernatural” intervention. At least one of the partici-
pants opined that the ‘endpoint (of all cancer diagnosis) is
death’ as shown in Table 3. Some participants suggested
that their strong faith in God and their spirituality would
ensure that God will cure them should they ever have
cancer. (Table 3) Some study participants said that they
or their relatives would prefer to seek alternate medicine
practitioners if they had cancer. They explained that the
reason for their patronage of alternative medicine practi-
tioners is because these practitioners were better at keep-
ing their diagnosis or treatment secret. There was no
difference in attitudes towards cancer between the
PLHIV and the non-PLHIV but more women than men
were of the opinion that God would not ‘allow’ them get
cancer. More participants in the south of the country
also demonstrated greater belief than those in the north
that God is ultimately the one to decide who gets cancer.
Practices of cancer screening
According to the FGD participants, many people, includ-
ing the FGD participants, were aware that there is screen-
ing for cancer (Table 4) but only few of the FGD
participants had actually been screened. They attributed
this low level of screening uptake to lack of knowledge
about the benefits of screening and the belief that it is bet-
ter to be ignorant of a diagnosis of cancer if one has no
symptoms of the disease as screening with resultant diag-
nosis of cancer can make you ‘die early’. The participants
associated screening with early mortality due to emotional
distress arising from cancer diagnosis. Although the parti-
cipants understood screening to mean testing for a par-
ticular disease, of the 3 participants who had been
screened for cervical cancer of the 48 eligible women, one
said the result was not disclosed to her while the other 2
said they had negative results. Only 6% of those eligible
for cervical cancer screening had ever been screened. (3 of
Table 2 Knowledge of Cancer and its causes among PLHIV and non-PLHIV in Nigerian tertiary health institutions
Knowledge Substantial finding Illustrative Quote
Knowledge of cancer Poor knowledge of cancer “Cancer is a deadly disease that has no cure” non-PLHIV respondent
“I believe it is a disease that is very rare in men. I have not heard
of any man who has had cancer and died but women die of breast
cancer” PLHIV respondent
Causes of cancer Limited knowledge of causes
of cancer
“I have heard that body creams cause cancer and also women who
put money in their bra (underwear) fit get cancer” PLHIV participant
“If one drinks dirty water from a dirty bowl or cup that is rusted,
one can get cancer” Non PLHIV
“Neglect can cause cancer, if an old person is neglected by their family,
they can get cancer” PLHIV respondent
Symptoms of cancer Symptoms of breast cancer most
commonly remembered
“Someone with cancer can have fever, pain and breast lump” Non
PLHIV respondent
Knowledge of HIV-associated
cancers (CC, KS and NHL)
Limited knowledge of HIV –associated
cancers among PLHIV
“I have no idea if HIV and Cancer are related” PLHIV respondent
“Kaposi what? Which one is that one again, me I never hear oh” (laughs)
PLHIV respondent. sic- (Kaposi what? what does that mean? I have never
heard of it).
“Cervical cancer is mainly on women on their private part” PLHIV
respondent
Treatment for cancer Poor knowledge of cancer treatment “Native leaves can also cure cancer, like back of mango fruit and guava
fruit” PLHIV respondent -(traditional leaves can cure cancer, like leaves
from mango fruit and guava fruit)
Misconceptions about cancer treatment “Herbalist can cure cancer” non-PLHIV respondent
“I heard that one can have operation and medicine to cure cancer if
caught early” PLH V respondent sic-(I heard that one can have surgery
and medications to cure cancer if caught early)
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48 female participants). Major concerns raised by the par-
ticipants included cost of screening and fear of a false posi-
tive diagnosis expressed particularly by a female participant
who said, ‘I know someone who was wrongly diagnosed of
HIV it can also happen with cancer, mistakes can happen’.
FGD participants with low levels of education in the north-
ern part of the country were concerned that screening is a
means of ‘inviting cancer to one’s body’ suggesting that
screening is associated with increased risk of cancer.
Key informant interviews
We interviewed 8 health care professionals (4 doctors and
4 nurses) who provide care for PLHIV at the 4 study sites.
Knowledge of cancer and AIDS associated cancers
Findings from the KII showed that although health
care professionals particularly doctors were aware of
cancer and had good knowledge of its causes, they
rarely discussed cancer in general or AIDS associated
cancers with HIV patients during clinic visits. The
health care professionals identified the causes of can-
cer to be smoking, past family history of cancer and
infectious agents. They also mentioned skin and leg
sores, vaginal bleeding, and neck swelling be suspi-
cious symptoms in PLHIV. Majority of the health
professionals were of the opinion that most PLHIV
lack basic knowledge about cancer and its causes and
they identified the need for cancer education in the
care and treatment of PLHIV.
“PLHIV need to be provided with more information on
cancer and its causes, it is true that we do not
routinely provide this information in the clinics as a
result of high caseload and lack of time”. Physician
Table 3 Attitudes towards cancer risk, diagnosis, and treatment among PLHIV and non-PLHIV in Nigerian tertiary
health institutions
Attitude Substantial
finding
Illustrative quotes
Attitude towards cancer diagnosis Fear “Once I hear cancer I feel very scared” PLWA respondent
Attitude towards risk of cancer among PLHIV Disbelief “It is not possible that someone who has HIV can have
cancer,
I do not believe it” PLHIV respondent
Attitude towards cancer treatment Fatalism “The endpoint of cancer is death,” non-PLHIV respondent
Denial “It is only God who is supernatural that can treat this disease”
non-PLHIV respondent
Attitude towards individual cancer risk “..me I no fit get cancer for my body” PLHIV respondent. sic-
(I cannot get cancer)
Table 4 Practices of cancer screening among PLHIV and non-PLHIV attending clinics in Nigerian tertiary hospitals
Practices of cancer screening Substantial finding Illustrative quotes
Knowledge of screening Participants were fairly knowledgeable of
what screening for cancer means.
“Screening is where the professionals check you to
know if you have cancer or not” PLHIV respondent
Reasons for poor screening
practices
Fear “They don’t want to do screening for cancer because
it is like asking God to give you the disease; it is like
inviting cancer to your body” non-PLHIV respondent
Cost “If the screening is free I will like to do it, the hospital
where I go to the screening for men is4000 naira, it
is too expensive” PLHIV respondent
Use of alternative health care “Some people do not want to go and do the test
because they are afraid that their secret will come
out, it is better to go to the herbalist where you will
not meet many people and the secret will be kept”
PLHIV respondent
General screening acceptability Participants expressed willingness to participate
in screening
“I will participate in any screening test in the hospital
because I want to know if I have cancer or not”
non-PLHIV respondent
Previous history of screening Only 3 participants in our study had ever been
screened for cancer.
“I was screened in the clinic for cervical cancer, it
was free. PLHIV respondent
Recommendations to improve
cancer information and cancer
screening practices
Participants mentioned mass and electronic media,
mobile text messaging, health talks and campaigns
as useful methods of disseminating information.
“They can give regular health talks at the hospitals and
offer free screening” PLHIV respondent
“You can go to different sport centers where youths
gather to watch football and spread the information”
non-PLHIV respondent
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Attitudes
There was general agreement that a diagnosis of cancer
is associated with fear. However, majority of the KII
respondents believe that cancer can be treated, if caught
early. One of the nurses mentioned that most times even
after treatment, cancer patients often die. Discussants
thought that cancer is becoming more common than in
the past and that even they as health workers could pos-
sibly be diagnosed of cancer.
‘Even as a health worker I am not immune to cancer,
anyone can get cancer, the important thing is to catch
it early.’ Nurse
Health care professionals mentioned that surgery and
chemotherapy were the most commonly used methods
of treatment for cancer in their institutions. There was a
general agreement that there is need to increase aware-
ness of cancer among not only PLHIV but the general
population.
Cancer screening practices
All the health care professionals interviewed had
heard of cancer screening, and were of the opinion
that screening is a necessary component of clinical
care for the general population and for PLHIV. Of
the 8 health care professional interviewed of which 5
were women and eligible for screening, 2 (40%) had
been screened for cancer (cervical cancer) as opposed
to. When the issue of cancer screening in PLHIV was
raised, they identified high cost as a major deterrent
to cancer screening in PLHIV. One of the health care
professionals was of the opinion that if screening is
done at minimal/no cost, there would be an increase
in screening uptake in Nigeria. She opined that “cost
is a major barrier to screening uptake in Nigeria; it is
just too expensive especially for people who are look-
ing for money to pay transportation costs to the hos-
pital, where do they now get the extra money to pay
for screening”.
When asked if they think that HIV positive patients
can get cancer, they all agreed that this was possible.
According to a medical doctor interviewed, “PLHIV just
like the general population are at risk of cancer and per-
haps a little more because of the additional risk HIV in-
fection confers”. However the health professionals
mentioned that cancer risk is not a topic that is routinely
discussed with PLHIV at clinic visits and PLHIV are not
routinely screened for cancer.
Mass media campaigns, television and radio adverts,
subsidized screening programs and health talks were
identified by the respondents as useful ways of dis-
seminating information on cancer to PLHIV and the
general population.
Discussion
PLHIV have a higher risk of malignancies than the gen-
eral population [19,26,27]. Therefore, we conducted
FGD and KII with the primary objective of evaluating
the knowledge, attitudes and practices of malignancies
among people living with HIV. In this study, we found
that most of our FGD participants had heard about can-
cer but had limited knowledge particularly of AIDS-
associated malignancies, causes of cancer and availability
of treatment. The participants expressed strong views on
the association between HIV and cancer with most be-
lieving that it is not possible to develop cancer if one
was already infected with HIV. Some of the participants
in the study expressed preference for alternative and
traditional means of diagnosis and treatment. Very few
participants in our study had ever been screened for any
cancer despite knowledge that screening for cancer
exists.
Findings from our study suggest poor knowledge of
cancer and its causes among the FGD participants.
This was surprising because we expected that PLHIV
would be better informed about cancers particularly
those associated with HIV given their more frequent
contact with the health care system. Our results sug-
gest the need for cancer education even in cohorts
with high levels of interaction with the health care
system such as PLHIV.
We observed that the attitudes of PLHIV in Nigeria
towards cancer were characterized by fear and low level
of perceived cancer risk. Majority of our participants
had heard about cancer screening, but very few had ever
been screened for cancer. Similarly low levels of cancer
screening had been reported in southeastern Nigeria, al-
though in a different target population [28]. Participants
in our study identified fear of diagnosis, fear of a false
positive diagnosis and cost as the primary barriers to the
uptake of cancer screening among PLHIV in Nigeria.
Most FGD participants who said they or their relatives
patronize alternate medical practitioners were those who
had attained secondary education or less. The literature
identifies poverty and lack of education as the reasons
for high patronage of complementary and alternative
medicine practitioners [17]. PLHIV in our study men-
tioned that they patronize alternate medical practitioners
because these practitioners are better at keeping patients’
diagnosis and treatment secret. This finding can be inter-
preted to mean that there is a level of distrust that
PLHIV associate with hospitals and health care profes-
sionals. It is also possible that PLHIV are concerned
about the complexity of services and personnel that they
interact with in the hospital and they believe that this
increases the risk of inadvertent disclosure in contrast to
alternative medicine practitioners which are often one
person establishments.
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With the recent attention paid to HIV/AIDS in Nigeria,
awareness of HIV/AIDS has substantially increased, how-
ever, cancer education and awareness remains poor [29].
More than 70% of all cancer patients in Nigeria present
with advanced disease [23], therefore opportunities to in-
corporate cancer screening into routine HIV care can play
a pivotal role in reducing the cancer burden among
PLHIV [21,29,30]. HIV clinics have expanded their opera-
tions to incorporate treatment of opportunistic infections
such as tuberculosis and they can similarly incorporate
cancer prevention, early diagnosis and treatment services.
This model has been successfully demonstrated by pro-
grams in Zambia and other parts of Africa with resultant
saving of lives [31,32].
Health care professionals including those caring for
PLHIV need to be trained to incorporate cancer pre-
vention and education services, and recognize the
early signs and symptoms of cancer, particularly those
prevalent among PLHIV. When coupled with coordi-
nated referral system, this can optimize the preven-
tion and management of cancer among PLHIV. Such
efforts are likely to be more effective if complemen-
ted by cancer education programs for the HIV/AIDS
patient population so they can appreciate and take
advantage of cancer prevention services. Such cancer
education can be delivered through electronic and
print media, mobile text messages, campaigns and
other health and educational programs as suggested
by our FGD participants.
Our findings are important because they show low
levels of cancer awareness among PLHIV despite their
high level of interaction with the health care system for
HIV treatment and prevention. This is similar to findings
from other studies that there is low level of cancer aware-
ness in Nigeria [28]. While the health care professionals
who participated in our KII were fairly knowledgeable of
cancer and AIDS associated cancers, the low levels of
awareness in the population they serve suggest that this
knowledge does not translate into screening, early detec-
tion and timely referral of cancer patients. Our results
demonstrate a need for clients’ and health professionals’
education to promote early detection of cancer and
increased use of cancer prevention services.
Furthermore, successful implementation of cancer
prevention and control strategies among PLHIV will
require a commitment by relevant government agen-
cies to the development of appropriate policies and
guidelines to support extra resources for community
health education and awareness, infrastructure devel-
opment, training of health care personnel on early
detection and diagnosis of AIDS associated malignan-
cies, subsidized cancer screening interventions and
the evaluation of cancer prevention strategies through
the promotion of research and cancer surveillance.
Provision of well-equipped pathology laboratories for
histologic examination of suspected cases of cancer is
also important.
Our study provides valuable information about current
knowledge, attitude and awareness of cancer among
PLHIV in Nigeria. It is however limited by the small
sample size and the use of qualitative research methods.
Nevertheless, qualitative methods are appropriate where
researchers need to probe for information that may be
unstructured and not amenable to survey methods. It is
also possible that the social interaction necessitated by
the FGD methods created an atmosphere where per-
ceived socially desirable responses had been given. Some
participants’ responses may have been influenced by
those of more vocal participants. However, we ensured
that quieter participants in the FGD had an opportunity
share their thoughts and contribute to the discussion. In
order to improve the generalizability of our results, we
randomly selected participants from high volume HIV/
AIDS centers in Nigeria and we believe that their opi-
nions were a true reflection of the situation among
PLHIV in Nigeria.
Conclusion
Our study shows that there is poor knowledge of cancer
and its causes among PLHIV in Nigeria and that there is
need to develop appropriate health education strategies to
promote cancer prevention, screening, and management.
These can incorporated into clinic visits for PLHIV and
training should be provided for health care professionals
on early diagnosis of AIDS-associated cancers. Further-
more, cancer control policies and guidelines for PLHIV
should be developed and implemented by relevant donor
and government agencies.
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